Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Bullous pemphigoid suggestive of complement-independent blister formation with anti-BP180 IgG4 autoantibodies.

Literature DB >> 26799363

Bullous pemphigoid suggestive of complement-independent blister formation with anti-BP180 IgG4 autoantibodies.

T Dainichi¹, W Nishie², Y Yamagami³, H Sonobe⁴, H Ujiie², Y Kaku^1,3, K Kabashima^1,5,6.

Abstract

Mesh：

Substances：

Year: 2016 PMID： 26799363 DOI： 10.1111/bjd.14411

Source DB: PubMed Journal: Br J Dermatol ISSN： 0007-0963 Impact factor: 9.302

Keyword Cloud
Cited

× No keyword cloud information.

12 in total

Review 1. A Review of the Immunologic Pathways Involved in Bullous Pemphigoid and Novel Therapeutic Targets.

Authors: Mohsen Afarideh; Robert Borucki; Victoria P Werth
Journal: J Clin Med Date: 2022-05-18 Impact factor: 4.964

2. IgG4 autoantibodies are inhibitory in the autoimmune disease bullous pemphigoid.

Authors: Yagang Zuo; Flor Evangelista; Donna Culton; Antonio Guilabert; Lin Lin; Ning Li; Luis Diaz; Zhi Liu
Journal: J Autoimmun Date: 2016-07-01 Impact factor: 7.094

Review 3. BP180 Is Critical in the Autoimmunity of Bullous Pemphigoid.

Authors: Yale Liu; Liang Li; Yumin Xia
Journal: Front Immunol Date: 2017-12-08 Impact factor: 7.561

4. Tissue Destruction in Bullous Pemphigoid Can Be Complement Independent and May Be Mitigated by C5aR2.

Authors: Christian M Karsten; Tina Beckmann; Maike M Holtsche; Jenny Tillmann; Sabrina Tofern; Franziska S Schulze; Eva Nina Heppe; Ralf J Ludwig; Detlef Zillikens; Inke R König; Jörg Köhl; Enno Schmidt
Journal: Front Immunol Date: 2018-03-15 Impact factor: 7.561

5. Preferential Reactivity of Dipeptidyl Peptidase-IV Inhibitor-Associated Bullous Pemphigoid Autoantibodies to the Processed Extracellular Domains of BP180.

Authors: Yosuke Mai; Wataru Nishie; Kentaro Izumi; Hiroshi Shimizu
Journal: Front Immunol Date: 2019-05-29 Impact factor: 7.561

Bullous pemphigoid suggestive of complement-independent blister formation with anti-BP180 IgG4 autoantibodies.

Review 1. A Review of the Immunologic Pathways Involved in Bullous Pemphigoid and Novel Therapeutic Targets.

2. IgG4 autoantibodies are inhibitory in the autoimmune disease bullous pemphigoid.

Review 3. BP180 Is Critical in the Autoimmunity of Bullous Pemphigoid.

4. Tissue Destruction in Bullous Pemphigoid Can Be Complement Independent and May Be Mitigated by C5aR2.

5. Preferential Reactivity of Dipeptidyl Peptidase-IV Inhibitor-Associated Bullous Pemphigoid Autoantibodies to the Processed Extracellular Domains of BP180.

Review 6. Lichen Planus Pemphigoides: From Lichenoid Inflammation to Autoantibody-Mediated Blistering.

Review 7. New Insights Into the Pathogenesis of Bullous Pemphigoid: 2019 Update.

Review 8. Milestones in Personalized Medicine in Pemphigus and Pemphigoid.

Review 9. The significance of preclinical anti-BP180 autoantibodies.

Review 10. Recent advances in the understanding and treatment of pemphigus and pemphigoid.